Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Targeting dermal adipocytes may help combat skin aging.

Nonionic liposomes are the best for delivering genes to skin cells.

Vitamin D receptor is crucial for starting hair growth after birth.

Melatonin affects mouse skin and may regulate skin functions.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

More research is needed to understand and manage rheumatoid arthritis better.